87 related articles for article (PubMed ID: 315624)
1. Studies on the thrombogenic activities in two prothrombin complex concentrates.
Hedner U; Nilsson IM; Bergentz SE
Thromb Haemost; 1979 Oct; 42(3):1022-32. PubMed ID: 315624
[No Abstract] [Full Text] [Related]
2. Pharmacokinetics, thrombogenicity and safety of a double viral inactivated factor IX concentrate compared with a prothrombin complex concentrate.
Ruiz-Sáez A; Hong A; Arguello A; Echenagucia M; Boadas A; Fabbrizzi F; Minichilli F; Bosch NB
Haemophilia; 2005 Nov; 11(6):583-8. PubMed ID: 16236107
[TBL] [Abstract][Full Text] [Related]
3. Comparison of high purity factor IX concentrates and a prothrombin complex concentrate in a canine model of thrombogenicity.
MacGregor IR; Ferguson JM; McLaughlin LF; Burnouf T; Prowse CV
Thromb Haemost; 1991 Nov; 66(5):609-13. PubMed ID: 1803625
[TBL] [Abstract][Full Text] [Related]
4. Prothrombin complex concentrates.
Penner JA
Bibl Haematol; 1977; 44():81-7. PubMed ID: 617787
[TBL] [Abstract][Full Text] [Related]
5. Various prothrombin complex concentrates and their effect on coagulation and fibrinolysis in vivo.
Hedner U; Nilsson IM; Bergentz SE
Thromb Haemost; 1976 Apr; 35(2):386-95. PubMed ID: 989639
[TBL] [Abstract][Full Text] [Related]
6. [State of local renal hemostasis in experimental nephritis after the administration of heparin, antithrombin III and prodectin].
Sokratov NV
Urol Nefrol (Mosk); 1985; (3):62-6. PubMed ID: 2409652
[No Abstract] [Full Text] [Related]
7. Potentially thrombogenic materials in factor IX concentrates.
Kingdon HS; Lundblad RL; Veltkamp JJ; Aronson DL
Thromb Diath Haemorrh; 1975 Jun; 33(3):617-31. PubMed ID: 1154317
[TBL] [Abstract][Full Text] [Related]
8. [Quality control of prothrombin complex preparations: in vivo and in vitro findings].
Köhler M; Habauer G; Miyashita C; Braun B; Mörsdorf S; Pindur G; Heiden M; Rose S; Ernert P
Beitr Infusionsther; 1990; 26():186-9. PubMed ID: 1703826
[TBL] [Abstract][Full Text] [Related]
9. Indications for administration of fresh frozen plasma and clotting factor concentrates.
Muntean W
Acta Anaesthesiol Scand Suppl; 1996; 109():139-41. PubMed ID: 8901985
[No Abstract] [Full Text] [Related]
10. Changes in coagulation and fibrinolysis after orthotopic canine liver homotransplantation.
Pechet L; Groth CG; Daloze PM
J Lab Clin Med; 1969 Jan; 73(1):91-102. PubMed ID: 4883102
[No Abstract] [Full Text] [Related]
11. A comparison of the in vitro and in vivo thrombogenic activity of factor IX concentrates using stasis (Wessler) and non-stasis rabbit models.
Prowse CV; Williams AE
Thromb Haemost; 1980 Oct; 44(2):81-6. PubMed ID: 6779401
[TBL] [Abstract][Full Text] [Related]
12. [Principles of the treatment of hypercoagulabilities with a rational anticoagulant therapy].
Raby C
Presse Med (1893); 1969 Jan; 77(1):17-9. PubMed ID: 5785756
[No Abstract] [Full Text] [Related]
13. [Effect of complexes of heparin with plasma proteins on the anticoagulant and fibrinolytic activity of blood].
Kudriashov BA; Pastorova VE; Liapina LA
Fiziol Zh SSSR Im I M Sechenova; 1986 Dec; 72(12):1653-8. PubMed ID: 3817209
[TBL] [Abstract][Full Text] [Related]
14. Biochemical and in vivo properties of high purity factor IX concentrates.
Berntorp E; Björkman S; Carlsson M; Lethagen S; Nilsson IM
Thromb Haemost; 1993 Nov; 70(5):768-73. PubMed ID: 8128433
[TBL] [Abstract][Full Text] [Related]
15. Effects of protease inhibitors on coagulation abnormalities in acute canine pancreatitis.
Izquierdo R; Sandberg L; Squillaci G; Hoppensteadt D; Walenga J; Fareed J; Prinz R
Am Surg; 1984 Jun; 50(6):317-23. PubMed ID: 6203448
[TBL] [Abstract][Full Text] [Related]
16. In vitro thrombogenicity tests of factor IX concentrates. II: effects of phospholipids and heparin.
Prowse CV; Boffa MC; Guthrie C; Pepper DS
Thromb Haemost; 1980 Feb; 42(5):1368-77. PubMed ID: 7368144
[TBL] [Abstract][Full Text] [Related]
17. [The action of peanut extract on the blood coagulation system].
Novak EN
Farmakol Toksikol; 1966; 29(5):568-71. PubMed ID: 5995068
[No Abstract] [Full Text] [Related]
18. Human coagulation factor IX: assessment of thrombogenicity in animal models and viral safety.
Herring SW; Abildgaard C; Shitanishi KT; Harrison J; Gendler S; Heldebrant CM
J Lab Clin Med; 1993 Mar; 121(3):394-405. PubMed ID: 8445288
[TBL] [Abstract][Full Text] [Related]
19. Activation of the coagulation cascade in patients with leptospirosis.
Chierakul W; Tientadakul P; Suputtamongkol Y; Wuthiekanun V; Phimda K; Limpaiboon R; Opartkiattikul N; White NJ; Peacock SJ; Day NP
Clin Infect Dis; 2008 Jan; 46(2):254-60. PubMed ID: 18171258
[TBL] [Abstract][Full Text] [Related]
20. [Preparation of prothrombin complex concentrates with reduced thrombogenicity].
Dornheim G
Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(6):856-62. PubMed ID: 6187638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
